243 related articles for article (PubMed ID: 36001680)
1. A genetically engineered
Murphy SC; Vaughan AM; Kublin JG; Fishbauger M; Seilie AM; Cruz KP; Mankowski T; Firat M; Magee S; Betz W; Kain H; Camargo N; Haile MT; Armstrong J; Fritzen E; Hertoghs N; Kumar S; Sather DN; Pinder LF; Deye GA; Galbiati S; Geber C; Butts J; Jackson LA; Kappe SHI
Sci Transl Med; 2022 Aug; 14(659):eabn9709. PubMed ID: 36001680
[TBL] [Abstract][Full Text] [Related]
2. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
[TBL] [Abstract][Full Text] [Related]
3. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH
Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408
[TBL] [Abstract][Full Text] [Related]
4. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.
Kublin JG; Mikolajczak SA; Sack BK; Fishbaugher ME; Seilie A; Shelton L; VonGoedert T; Firat M; Magee S; Fritzen E; Betz W; Kain HS; Dankwa DA; Steel RW; Vaughan AM; Noah Sather D; Murphy SC; Kappe SH
Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053159
[TBL] [Abstract][Full Text] [Related]
5. IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
Hickey B; Teneza-Mora N; Lumsden J; Reyes S; Sedegah M; Garver L; Hollingdale MR; Banania JG; Ganeshan H; Dowler M; Reyes A; Tamminga C; Singer A; Simmons A; Belmonte M; Belmonte A; Huang J; Inoue S; Velasco R; Abot S; Vasquez CS; Guzman I; Wong M; Twomey P; Wojnarski M; Moon J; Alcorta Y; Maiolatesi S; Spring M; Davidson S; Chaudhury S; Villasante E; Richie TL; Epstein JE
PLoS One; 2020; 15(6):e0233840. PubMed ID: 32555601
[TBL] [Abstract][Full Text] [Related]
6. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR; Meij P; Wessels E; Teelen K; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GJ; Visser LG; van der Ven AJAM; de Mast Q; Natasha KC; Abebe Y; Murshedkar T; Billingsley PF; Richie TL; Sim BKL; Janse CJ; Hoffman SL; Khan SM; Sauerwein RW
Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434847
[TBL] [Abstract][Full Text] [Related]
8. A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion.
Mikolajczak SA; Lakshmanan V; Fishbaugher M; Camargo N; Harupa A; Kaushansky A; Douglass AN; Baldwin M; Healer J; O'Neill M; Phuong T; Cowman A; Kappe SH
Mol Ther; 2014 Sep; 22(9):1707-15. PubMed ID: 24827907
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
[TBL] [Abstract][Full Text] [Related]
10. Protection against
Epstein JE; Paolino KM; Richie TL; Sedegah M; Singer A; Ruben AJ; Chakravarty S; Stafford A; Ruck RC; Eappen AG; Li T; Billingsley PF; Manoj A; Silva JC; Moser K; Nielsen R; Tosh D; Cicatelli S; Ganeshan H; Case J; Padilla D; Davidson S; Garver L; Saverino E; Murshedkar T; Gunasekera A; Twomey PS; Reyes S; Moon JE; James ER; Kc N; Li M; Abot E; Belmonte A; Hauns K; Belmonte M; Huang J; Vasquez C; Remich S; Carrington M; Abebe Y; Tillman A; Hickey B; Regules J; Villasante E; Sim BKL; Hoffman SL
JCI Insight; 2017 Jan; 2(1):e89154. PubMed ID: 28097230
[No Abstract] [Full Text] [Related]
11. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
12. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
[TBL] [Abstract][Full Text] [Related]
13. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
[TBL] [Abstract][Full Text] [Related]
14. Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial.
van der Boor SC; Alkema M; van Gemert GJ; Teelen K; van de Vegte-Bolmer M; Walk J; van Crevel R; de Mast Q; Ockenhouse CF; Sauerwein RW; McCall MBB
BMC Med; 2023 Apr; 21(1):137. PubMed ID: 37024868
[TBL] [Abstract][Full Text] [Related]
15. Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL; Church LWP; Murshedkar T; Billingsley PF; James ER; Chen MC; Abebe Y; Natasha Kc ; Chakravarty S; Dolberg D; Healy SA; Diawara H; Sissoko MS; Sagara I; Cook DM; Epstein JE; Mordmüller B; Kapulu M; Kreidenweiss A; Franke-Fayard B; Agnandji ST; López Mikue MA; McCall MBB; Steinhardt L; Oneko M; Olotu A; Vaughan AM; Kublin JG; Murphy SC; Jongo S; Tanner M; Sirima SB; Laurens MB; Daubenberger C; Silva JC; Lyke KE; Janse CJ; Roestenberg M; Sauerwein RW; Abdulla S; Dicko A; Kappe SHI; Sim BKL; Duffy PE; Kremsner PG; Hoffman SL
Expert Rev Vaccines; 2023; 22(1):964-1007. PubMed ID: 37571809
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
[TBL] [Abstract][Full Text] [Related]
17. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE;
Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641
[TBL] [Abstract][Full Text] [Related]
18. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.
Schats R; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; van Lieshout L; Haks MC; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW
PLoS One; 2015; 10(5):e0124243. PubMed ID: 25933168
[TBL] [Abstract][Full Text] [Related]
19. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.
Walk J; Reuling IJ; Behet MC; Meerstein-Kessel L; Graumans W; van Gemert GJ; Siebelink-Stoter R; van de Vegte-Bolmer M; Janssen T; Teelen K; de Wilt JHW; de Mast Q; van der Ven AJ; Diez Benavente E; Campino S; Clark TG; Huynen MA; Hermsen CC; Bijker EM; Scholzen A; Sauerwein RW
BMC Med; 2017 Sep; 15(1):168. PubMed ID: 28903777
[TBL] [Abstract][Full Text] [Related]
20. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.
Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B
Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
